Prostate-specific membrane antigen-directed imaging and radioguided surgery with single-photon emission computed tomography: state of the art and future outlook

References

• Leslie SW, Soon-Sutton TL, Sajjad H, et al. Prostate Cancer. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022; (citied: 2022, May, 11). Available from:http://www.ncbi.nlm.nih.gov/books/NBK470550/
   Google Scholar
• Crawford ED, Koo PJ, Shore N, et al. A clinician’s guide to next generation imaging in patients with advanced prostate cancer (RADAR III). J Urol. 2019;201:682–692.
   PubMed Web of Science ®Google Scholar
• Tateishi U. Prostate-specific membrane antigen (PSMA)–ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer. Jpn J Clin Oncol. 2020;50:349–356.
   PubMed Web of Science ®Google Scholar
• Wester H-J, Schottelius M. PSMA-Targeted radiopharmaceuticals for imaging and therapy. Semin Nucl Med. 2019;49:302–312.
   PubMed Web of Science ®Google Scholar
• Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395:1208–1216.
   PubMed Web of Science ®Google Scholar
• Filippi L, Chiaravalloti A, Schillaci O, et al. The potential of PSMA-targeted alpha therapy in the management of prostate cancer. Expert Rev Anticancer Ther. 2020;20:823–829.
   PubMed Web of Science ®Google Scholar
• Kairemo K, Joensuu T. Lu-177-PSMA treatment for metastatic prostate cancer: case examples of major responses. Clin Transl Imaging. 2018;6:223–237.
   Web of Science ®Google Scholar
• Frantellizzi V, Cosma L, Brunotti G, et al. Targeted alpha therapy with thorium-227. Cancer Biother Radiopharm. 2020;35:437–445.
   PubMed Web of Science ®Google Scholar
• Vahidfar N, Eppard E, Farzanehfar S, et al. An impressive approach in nuclear medicine. PET Clin. 2021;16:327–340.
   PubMed Web of Science ®Google Scholar
• Cimini A, Ricci M, Chiaravalloti A, et al. Theragnostic aspects and radioimmunotherapy in pediatric tumors. Int J Mol Sci. 2020;21(11):E3849.
   PubMed Web of Science ®Google Scholar
• Strauss DS, Sachpekidis C, Kopka K, et al. Pharmacokinetic studies of [68 Ga]Ga-PSMA-11 in patients with biochemical recurrence of prostate cancer: detection, differences in temporal distribution and kinetic modelling by tissue type. Eur J Nucl Med Mol Imaging. 2021;48(13):4472–4482.
   PubMed Web of Science ®Google Scholar
• Filippi L, Schillaci O. SPECT/CT with a hybrid camera: a new imaging modality for the functional anatomical mapping of infections. Expert Rev Med Devices. 2006;3(6):699–703.
   PubMed Web of Science ®Google Scholar
• Israel O, Pellet O, Biassoni L, et al. Two decades of SPECT/CT – the coming of age of a technology: an updated review of literature evidence. Eur J Nucl Med Mol Imaging. 2019;46:1990–2012.
   PubMed Web of Science ®Google Scholar
• Filippi L, Biancone L, Petruzziello C, et al. Tc-99m HMPAO-labeled leukocyte scintigraphy with hybrid SPECT/CT detects perianal fistulas in crohn disease. Clin Nucl Med. 2006;31:541–542.
   PubMed Web of Science ®Google Scholar
• Ritt P. Recent Developments in SPECT/CT. Semin Nucl Med. 2022;52:276–285.
   PubMed Web of Science ®Google Scholar
• Filippi L, Valentini FB, Gossetti B, et al. Intraoperative gamma probe detection of head and neck paragangliomas with 111In-pentetreotide: a pilot study. Tumori. 2005;91:173–176.
   PubMed Web of Science ®Google Scholar
• Povoski SP, Neff RL, Mojzisik CM, et al. A comprehensive overview of radioguided surgery using gamma detection probe technology. World J Surg Onc. 2009;7:11.
   PubMed Web of Science ®Google Scholar
• Follacchio GA, Monteleone F, Anibaldi P, et al. A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study. J Exp Clin Cancer Res. 2015;34:113.
   PubMed Web of Science ®Google Scholar
• Ilisie V, Moliner L, Oliver S, et al. High resolution and sensitivity gamma camera with active septa. A first Monte Carlo study. Sci Rep. 2019;9:18431.
   PubMed Web of Science ®Google Scholar
• Kuwert T, Schillaci O. SPECT/CT: yesterday, today, tomorrow. Clin Transl Imaging. 2014;2:443–444.•Comprehensive review on the most relevant applications of hybrid SPECT/CT technology.
   Google Scholar
• Palmedo H, Marx C, Ebert A, et al. Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients. Eur J Nucl Med Mol Imaging. 2014;41:59–67.
   PubMed Web of Science ®Google Scholar
• Abikhzer G, Gourevich K, Kagna O, et al. Whole-body bone SPECT in breast cancer patients: the future bone scan protocol? Nucl Med Commun. 2016;37:247–253.
   PubMed Web of Science ®Google Scholar
• Jh O, Wahl RL. PERCIST in Perspective. Nucl Med Mol Imaging. 2018;52:1–4.
   PubMed Web of Science ®Google Scholar
• Filippi L, Di Costanzo GG, Tortora R, et al. Prognostic value of neutrophil-to-lymphocyte ratio and its correlation with fluorine-18-fluorodeoxyglucose metabolic parameters in intrahepatic cholangiocarcinoma submitted to 90Y-radioembolization. Nucl Med Commun. 2020;41:78–86.
   PubMed Web of Science ®Google Scholar
• Dickson J, Ross J, Vöö S. Quantitative SPECT: the time is now. EJNMMI Phys. 2019;6:4.
   PubMed Web of Science ®Google Scholar
• D’Arienzo M, Pimpinella M, Capogni M, et al. Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization. EJNMMI Res. 2017;7:94.
   PubMed Web of Science ®Google Scholar
• Sarikaya I, Sarikaya A, Reba RC. Gamma probes and their use in tumor detection in colorectal cancer. Int Semin Surg Oncol. 2008;5:25.
   PubMedGoogle Scholar
• Pashazadeh A, Friebe M. Radioguided surgery: physical principles and an update on technological developments. Biomed Eng/Biomed Tech. 2020;65:1–10.
   PubMed Web of Science ®Google Scholar
• Mariani G, Vaiano A, Nibale O, et al. Is the “ideal” gamma-probe for intraoperative radioguided surgery conceivable? J Nucl Med. 2005;46:388–390.•Interesting paper discussing pros and cons of scintillation and semiconductor-ionization gamma probes.
   PubMed Web of Science ®Google Scholar
• Heller S, Zanzonico P. Nuclear probes and intraoperative gamma cameras. Semin Nucl Med. 2011;41:166–181.
   PubMed Web of Science ®Google Scholar
• Gonzalez‐Montoro A, Vera‐Donoso CD, Konstantinou G, et al. Nuclear‐medicine probes: where we are and where we are going. Med Phys. 2022;49:4372–4390.
   PubMed Web of Science ®Google Scholar
• Lamb HM, Faulds D. Capromab pendetide: a Review of its use as an imaging agent in prostate cancer. Drugs Aging. 1998;12:293–304.
   PubMed Web of Science ®Google Scholar
• O’Keefe DS, Bacich DJ, Huang SS, et al. A perspective on the evolving story of PSMA Biology, PSMA-Based imaging, and endoradiotherapeutic strategies. J Nucl Med. 2018;59:1007–1013.
   PubMed Web of Science ®Google Scholar
• Brunello S, Salvarese N, Carpanese D, et al. A review on the current state and future perspectives of [99mTc]Tc-Housed PSMA-i in prostate cancer. Molecules. 2022;27:2617.
   PubMed Web of Science ®Google Scholar
• Chatalic KLS, Heskamp S, Konijnenberg M, et al. Towards personalized treatment of prostate cancer: PSMA I&T, a promising prostate-specific membrane antigen-targeted theranostic agent. Theranostics. 2016;6:849–861.
   PubMed Web of Science ®Google Scholar
• Schottelius M, Wirtz M, Eiber M, et al. [111In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery. EJNMMI Res. 2015;5:68.
   PubMed Web of Science ®Google Scholar
• Benešová M, Schäfer M, Bauder-Wüst U, et al. Preclinical Evaluation of a tailor-made DOTA-Conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer. J Nucl Med. 2015;56:914–920.
   PubMed Web of Science ®Google Scholar
• van der Sar Eca, Kühr AJS, Ebbers SC, et al. Baseline imaging derived predictive factors of response following [177Lu]Lu-PSMA-617 therapy in salvage metastatic castration-resistant prostate cancer: a lesion- and patient-based analysis. Biomedicines. 2022;10:1575.
   PubMed Web of Science ®Google Scholar
• Heidegger I, Kesch C, Kretschmer A, et al. Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review. Ther Adv Med Oncol. 2022;14:175883592210819.
   Web of Science ®Google Scholar
• Boschi A, Uccelli L, Martini P. A picture of modern Tc-99m Radiopharmaceuticals: production, chemistry, and applications in molecular imaging. Appl Sci. 2019;9:2526.
   Google Scholar
• Robu S, Schottelius M, Eiber M, et al. Preclinical evaluation and first patient application of 99m Tc-PSMA-I&S for SPECT imaging and radioguided surgery in prostate cancer. J Nucl Med. 2017;58:235–242.
   PubMed Web of Science ®Google Scholar
• Rauscher I, Maurer T, Souvatzoglou M, et al. Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in patients with early recurrent prostate cancer. Clin Nucl Med. 2016;41:e397–402.
   PubMed Web of Science ®Google Scholar
• Rauscher I, Düwel C, Wirtz M, et al. Value of 111 In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up. BJU Int. 2017;120:40–47.
   PubMed Web of Science ®Google Scholar
• Mix M, Reichel K, Stoykow C, et al. Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy. Eur J Nucl Med Mol Imaging. 2018;45:2062–2070.•Valuable research paper focused on the first applications of PSMA radioguided surgery.
   PubMed Web of Science ®Google Scholar
• Jilg CA, Reichel K, Stoykow C, et al. Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer. EJNMMI Res. 2020;10:17.
   PubMed Web of Science ®Google Scholar
• Mix M, Schultze-Seemann W, von Büren M, et al. 99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle. EJNMMI Res. 2021;11:22.
   PubMed Web of Science ®Google Scholar
• Vats K, Agrawal K, Sharma R, et al. Preparation and clinical translation of 99m Tc-PSMA-11 for SPECT imaging of prostate cancer. Med Chem Commun. 2019;10:2111–2117.
   Google Scholar
• Schmidkonz C, Hollweg C, Beck M, et al. 99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer. Prostate. 2018;78:54–63.
   PubMed Web of Science ®Google Scholar
• Afshar-Oromieh A, Avtzi E, Giesel FL, et al. The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2015;42:197–209.
   PubMed Web of Science ®Google Scholar
• Werner P, Neumann C, Eiber M, et al. [99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center. EJNMMI Res. 2020;10:45.
   PubMed Web of Science ®Google Scholar
• Sergieva S, Mangaldgiev R, Dimcheva M, et al. SPECT-CT imaging with 99mTc-PSMAin patients with recurrent prostate cancer. Nucl Med Rev. 2021;24:70–81.
   PubMed Web of Science ®Google Scholar
• Li P, Liu C, Wu S, et al. Combination of 99mTc-Labeled PSMA-SPECT/CT and diffusion-weighted MRI in the prediction of early response after carbon ion therapy in prostate cancer: a non-randomized prospective pilot study. Cancer Manag Res. 2021;13:2191–2199.
   PubMed Web of Science ®Google Scholar
• Albalooshi B, Al Sharhan M, Bagheri F, et al. Direct comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer. Asia Ocean J Nucl Med Biol. 2020. DOI:10.22038/aojnmb.2019.43943.1293.
   PubMedGoogle Scholar
• Singh B, Sharma S, Bansal P, et al. Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality. Nucl Med Commun. 2021;42:482–489.
   PubMed Web of Science ®Google Scholar
• Fallahi B, Khademi N, Karamzade-Ziarati N, et al. 99mTc-PSMA SPECT/CT Versus 68Ga-PSMA PET/CT in the evaluation of metastatic prostate cancer. Clin Nucl Med. 2021;46:e68–74.
   PubMed Web of Science ®Google Scholar
• Pani R, Pellegrini R, Cinti MN, et al. New devices for imaging in nuclear medicine. Cancer Biother Radiopharm. 2004;19:121–128.
   PubMed Web of Science ®Google Scholar
• Dietze MMA, de Jong HWAM. Progress in large field-of-view interventional planar scintigraphy and SPECT imaging. Expert Rev Med Devices. 2022;19:393–403.•Valuable review paper on the innovative technology of large field-of-view handheld gamma cameras.
   PubMed Web of Science ®Google Scholar
• Ferraro DA, Becker AS, Kranzbühler B, et al. Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study. Eur J Nucl Med Mol Imaging. 2021;48:3315–3324.
   PubMed Web of Science ®Google Scholar
• de Barros Ha, van Oosterom Mn, Donswijk ML, et al. Robot-assisted prostate-specific membrane antigen-radioguided salvage surgery in recurrent prostate cancer using a DROP-IN gamma probe: the first prospective feasibility study. Eur Urol. 2022;82:97–105.
   PubMed Web of Science ®Google Scholar
• Gordon LG, Elliott TM, Joshi A, et al. Exploratory cost-effectiveness analysis of 68Gallium-PSMA PET/MRI-based imaging in patients with biochemical recurrence of prostate cancer. Clin Exp Metastasis. 2020;37:305–312.
   PubMed Web of Science ®Google Scholar
• Katal S, Eibschutz LS, Saboury B, et al. Advantages and applications of total-body PET scanning. Diagnostics. 2022;12:426.
   Web of Science ®Google Scholar
• Filippi L, Schillaci OT-B. [18F]FDG PET/CT scan has stepped into the arena: the faster, the better. Is it always true? Eur J Nucl Med Mol Imaging. 2022;49:3322–3327.
   PubMed Web of Science ®Google Scholar
• Ismail FS, Mansor S. Impact of resolution recovery in quantitative 99mTc SPECT/CT cardiac phantom studies. J Med Imaging Radiat Sci. 2019;50:449–453.
   PubMed Web of Science ®Google Scholar